Newsletter sign up

Sign up for Medicilon's newsletter below.

Search Medicilon

Preclinical CRO

【BRIDGE】Medicilon XDC Innovation Forum · Seoul 2026

Preclinical CRO

Medicilon’s Formulation CDMO Platform Advances Taiji Group’s Next-Generation RNA Polymerase Inhibitor DSC158A Tablets to Clinical Stage

Preclinical CRO

TPD CN-US Dual Filing Milestone: Medicilon’s One-Stop Platform Helps Gluetacs Secure Dual Approval for GT818, a First-in-Class RSK Degrader

Contact Medicilon

Name(Required)
Address(Required)